Editas Medicine Inc (EDIT) Insider Trading
- $2,896,814.00
- $51,407,073.78
- Aug. 7, 2025
- Katrine Bosley
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 15, 2017 | CFO | 5,000 | $24.31 | Sell | $121,550.00 | |
| Dec. 1, 2017 | Insider | 8,333 | $29.58 | Sell | $246,490.14 | |
| Nov. 20, 2017 | CFO | 5,000 | $25.35 | Sell | $126,750.00 | |
| Nov. 17, 2017 | CFO | 5,000 | $24.81 | Sell | $124,050.00 | |
| Nov. 1, 2017 | Insider | 8,333 | $23.64 | Sell | $196,992.12 | |
| Oct. 2, 2017 | Insider | 8,333 | $24.78 | Sell | $206,491.74 | |
| Sept. 5, 2017 | Insider | 16,666 | $20.33 | Sell | $338,819.78 | |
| Sept. 1, 2017 | CEO | 10,000 | $20.42 | Sell | $204,200.00 | |
| Aug. 11, 2017 | Insider | 16,666 | $20.02 | Sell | $333,653.32 | |
| June 2, 2017 | Insider | 4,000 | $14.15 | Buy | $56,600.00 | |
| June 2, 2017 | Director | 35,000 | $14.07 | Buy | $492,450.00 | |
| May 22, 2017 | Director | 1,000,000 | $17.00 | Sell | $17,000,000.00 | |
| March 15, 2017 | COO | 1,000 | $26.41 | Sell | $26,410.00 | |
| Feb. 15, 2017 | COO | 6,000 | $20.58 | Sell | $123,480.00 | |
| Feb. 15, 2017 | CFO | 3,000 | $19.20 | Sell | $57,600.00 | |
| Jan. 11, 2017 | CFO | 15,000 | $19.20 | Sell | $288,000.00 | |
| Dec. 7, 2016 | Major Shareholder | 75,000 | $15.82 | Sell | $1,186,500.00 | |
| Dec. 6, 2016 | Director | 130,000 | $15.79 | Sell | $2,052,700.00 | |
| Nov. 23, 2016 | Director | 21,480 | $15.71 | Sell | $337,450.80 | |
| Nov. 22, 2016 | Major Shareholder | 12,819 | $15.77 | Sell | $202,155.63 | |
| Nov. 15, 2016 | Director | 88,900 | $16.96 | Sell | $1,507,744.00 | |
| Sept. 8, 2016 | Major Shareholder | 500,000 | $16.80 | Sell | $8,400,000.00 | |
| Sept. 6, 2016 | Major Shareholder | 5,890 | $15.90 | Sell | $93,651.00 | |
| Aug. 23, 2016 | COO | 1,000 | $20.00 | Sell | $20,000.00 | |
| Feb. 8, 2016 | Insider | 100,000 | $16.00 | Buy | $1,600,000.00 |
Insiders are both buying and selling Editas Medicine Inc stock.
The insider traders at Editas Medicine Inc are: Katrine Bosley, Bruce Eaton, Andrew A F Hack, Vickesh Myer, Michelle Robertson, Charles Albright, Baisong Mei, Gilmore Neil O'neill, Kevin Bitterman, Alexandra Glucksmann, Jessica Hopfield, Linda Burkly, Polaris Venture Management Co., Amy Parison, Cynthia Collins, Mark S Shearman, James C Mullen, James E Flynn, Gerald Frank Cox, Boris Nikolic, Kevin P. Starr, and Lisa Anne Michaels
The most active insider trader at Editas Medicine Inc is Katrine Bosley with 23 trades.
Kevin Bitterman has sold the most Editas Medicine Inc stock with a total value of $37,897,894.80.
James E Flynn has bought the most Editas Medicine Inc stock with a total value of $3,200,000.00.
The most recent insider trade for Editas Medicine Inc was on Aug. 7, 2025.
The single biggest insider buy for Editas Medicine Inc was from James E Flynn with a total value of $1,600,000.00 on Feb. 8, 2016.
The single biggest insider sell for Editas Medicine Inc was from Kevin Bitterman with a total value of $17,000,000.00 on May 22, 2017.